Cargando…
The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism
Fibroblast growth factor-23 (FGF23), a phosphate(Phos)-regulating hormone, is abnormally elevated in hypophosphataemic syndromes and an elevated FGF23 is a predictor of mortality in kidney disease. Recent findings suggest iron deficiency as a potential mediator of FGF23 expression and murine studies...
Autores principales: | Braithwaite, V.S., Prentice, A., Darboe, M.K., Prentice, A.M., Moore, S.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720219/ https://www.ncbi.nlm.nih.gov/pubmed/26453792 http://dx.doi.org/10.1016/j.bone.2015.10.003 |
Ejemplares similares
-
Iron status and fibroblast growth factor-23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2012) -
Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: Possible aetiological factors()()
por: Braithwaite, Vickie, et al.
Publicado: (2012) -
FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study
por: Braithwaite, Vickie, et al.
Publicado: (2012) -
Long-term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake
por: Ward, Kate Anna, et al.
Publicado: (2017) -
Intact fibroblast growth factor 23 and fragments in plasma from Gambian children
por: Braithwaite, V., et al.
Publicado: (2012)